Skip to Main Content
BLACK FRIDAY SALE

60% off Quiver Premium for new subscribers

...

Use Promo Code:

BLACKFRIDAY26
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

APNIMED ($APMD) Releases Q3 2026 Earnings, Stock Rises

None

APNIMED ($APMD) posted quarterly earnings results for Q3 2026 on Monday, November 16th. The company reported earnings of -$0.99 per share, missing estimates of -$0.62 by $0.37. The company also reported revenue of $0, equaling estimates of $0 by $0.

Stock price change since market open this morning: +1.44%

You can see Quiver Quantitative's $APMD stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

APNIMED Insider Trading Activity

APNIMED insiders have traded $APMD stock on the open market 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $APMD stock by insiders over the last 6 months:

  • VENTURE INVESTMENTS LTD MORNINGSIDE purchased 312,500 shares for an estimated $5,000,000
  • PAUL J SEKHRI purchased 12,500 shares for an estimated $200,000

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

APNIMED Hedge Fund Activity

We have seen 51 institutional investors add shares of APNIMED stock to their portfolio, and 0 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

APNIMED Analyst Ratings

Wall Street analysts have issued reports on $APMD in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • LifeSci Capital issued a "Outperform" rating on 08/25/2026
  • Cantor Fitzgerald issued a "Overweight" rating on 08/25/2026
  • Evercore ISI Group issued a "Outperform" rating on 08/25/2026
  • B of A Securities issued a "Buy" rating on 08/25/2026

To track analyst ratings and price targets for APNIMED, check out Quiver Quantitative's $APMD forecast page.

APNIMED Price Targets

Multiple analysts have issued price targets for $APMD recently. We have seen 3 analysts offer price targets for $APMD in the last 6 months, with a median target of $50.0.

Here are some recent targets:

  • Francois Brisebois from LifeSci Capital set a target price of $50.0 on 08/25/2026
  • Josh Schimmer from Cantor Fitzgerald set a target price of $60.0 on 08/25/2026
  • Jason Gerberry from B of A Securities set a target price of $41.0 on 08/25/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles